Hope on the Horizon: MoonLake’s Sonelokimab Delivers Breakthrough 52-Week Results in the Battle Against Hidradenitis Suppurativa
Executive Overview For the estimated millions of individuals worldwide grappling with hidradenitis suppurativa (HS)—a chronic, inflammatory, and profoundly…
